Delivery Order SPE2DB22D2214-SPE2DB25FS4XV
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $16,561.84 for the supply of Teriparatide 560mcg/2.24ml pens. This firm fixed price, competitively awarded contract was issued by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $90,086.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Teriparatide 560 mcg/2.24 ml pens with a completion date of June 4, 2025. This contract utilizes no set-aside designation and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement valued through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,864.82 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with an ultimate completion date of November 28, 2025. This non-set-aside, firm fixed price contract represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Teriparatide 560mcg/2.24mL pens valued at $2,158.86. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion deadline of December 2, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement...
- The Defense Logistics Agency awarded a $13,502.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Teriparatide 560mcg/2.24ml pens. The contract requires completion by December 2, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,286.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens on September 8, 2025, with completion scheduled for September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, with a ceiling value of $14,083.38 and an ultimate completion date of November 25, 2025. This is a non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,758.48 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pens on November 4, 2025, with completion scheduled for November 5, 2025. This non-competitive delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $3,176.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections, with an ultimate completion date of December 10, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle valued...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.84 to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a pediatric/adult osteoporosis treatment pharmaceutical product, delivered from the vendor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation and is issued as a child contract under...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS4XVDelivery Order
The Defense Logistics Agency awarded a $7,485.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 MCG/2.24 ML pens on May 8, 2025, with completion expected by May 9, 2025. This non-set-aside contract represents a pediatric delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and veteran healthcare systems. Teriparatide is a bone-building medication used in the treatment of osteoporosis and related bone disorders. This delivery order falls within AmerisourceBergen's extensive portfolio of pharmaceutical supply contracts with the DLA, which encompasses specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains in support of military healthcare programs worldwide. The award demonstrates the company's continued capability to meet federal procurement requirements through competitive contracting processes and underscores its role as a critical vendor for federal medical supply chain operations serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 5/8/25 |